Sugi Predict

Sugi Predict / Compounds / SCHEMBL68891

SCHEMBL68891

SCHEMBL68891

COC(=O)c1cc2ccccc2nc1C(=O)OC

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.51
▸ ALDH1A1 P00352 4/20 0.49
▸ HPGD P15428 2/20 0.49
▸ NPSR1 Q6W5P4 2/20 0.49
▸ ABCG2 Q9UNQ0 1/20 0.47
▸ MAPT P10636 2/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ IKBKB O14920 1/20 0.46
▸ HTT P42858 2/20 0.45
▸ ALOX15 P16050 1/20 0.45
▸ SLC6A2 P23975 1/20 0.45
▸ SLC6A4 P31645 1/20 0.45
▸ SLC6A3 Q01959 1/20 0.45
▸ LMNA P02545 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ MEN1 O00255 3/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ RXFP1 Q9HBX9 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28703252 0.90 KDM4E (0.49) KDM4EALDH1A1HPGDNPSR1ABCG2
SCHEMBL6232818 0.90 KDM4E (0.52) KDM4EALDH1A1HPGDNPSR1ABCG2
SCHEMBL9631891 0.90 KDM4E (0.49) KDM4EALDH1A1HPGDNPSR1ABCG2
SCHEMBL16234345 0.83 KDM4E (0.51) KDM4EALDH1A1HPGDNPSR1ABCG2
SCHEMBL8905796 0.83 TDP1 (0.47) KDM4EALDH1A1HPGDNPSR1MAPT
SCHEMBL6535899 0.83 KDM4E (0.51) KDM4EALDH1A1HPGDNPSR1ABCG2
SCHEMBL30201832 0.83 SMN1; SMN2 (0.60) KDM4EALDH1A1HPGDNPSR1MAPT
SCHEMBL28568289 0.83 CDC25B (0.49) KDM4EALDH1A1HPGDNPSR1MAPT
SCHEMBL5255504 0.82 IKBKB (0.66) KDM4EALDH1A1HPGDNPSR1ABCG2
SCHEMBL3364626 0.82 TLR8 (0.46) KDM4EALDH1A1HPGDNPSR1ABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113912538-A Preparation method of quinoline compound 沈阳中化农药化工研发有限公司 2022-01-11 — — CN disclosed
CN-101781247-B New method for synthesizing substituted 3-quinoline carboxylic acid and analogue UNIV SHANGHAI MARITIME 2013-01-02 — — CN disclosed
EP-2479203-A1 AROMATIC POLYESTER Muroran Institute of Technology (JP) 2012-07-25 — — EP disclosed
US-20120172570-A1 AROMATIC POLYESTER NITTA CORPORATION 2012-07-05 — — US disclosed
US-8129493-B2 Aromatic polyester MURORAN INSTITUTE OF TECHNOLOGY (JP) 2012-03-06 — — US disclosed
US-20110224343-A1 MODIFIER FOR AROMATIC POLYESTER AND AROMATIC POLYESTER RESIN COMPOSITION COMPRISING THE SAME MURORAN INSTITUTE OF TECHNOLOGY (JP) 2011-09-15 — — US disclosed
US-20110092662-A1 AROMATIC POLYESTER NITTA CORPORATION (JP) 2011-04-21 — — US disclosed
CN-101781247-A New method for synthesizing substituted 3-quinoline carboxylic acid and analogue UNIV SHANGHAI MARITIME 2010-07-21 — — CN disclosed
EP-1004582-B1 Pyridazino quinoline compounds ASTRAZENECA AB (SE) 2005-05-18 — — EP disclosed
EP-0931081-B1 PYRIDAZINO 4,5-B]-QUINOLINE 5-OXIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS GLYCINE ANTAGONISTS MERZ & CO GMBH & CO (DE) 2002-09-25 — — EP disclosed
US-5599814-A SUBSTITUTED PYRIDAZINO(4,5-B)QUINOLINES AS ANTAGONISTS OF EXCITATORY AMINO ACIDS IMPERIAL CHEMICAL INDUSTRIES, PLC (GB) 1997-02-04 — — US disclosed
EP-0516297-B1 Pyridazinediones and their use in the treatment of neurological disorders ZENECA LTD (GB) 1996-10-30 — — EP disclosed
EP-0736531-A1 Alpha-substituted pyridazino quinoline compounds ZENECA LIMITED (GB) 1996-10-09 — — EP disclosed
EP-0724583-A1 PYRIDAZINO QUINOLINE COMPOUNDS ZENECA LIMITED (GB) 1996-08-07 — — EP disclosed
WO-1996015127-A1 PYRIDAZINOQUINOLINE COMPOUNDS ZENECA LIMITED (GB) 1996-05-23 — — WO disclosed
WO-1995011244-A1 PYRIDAZINO QUINOLINE COMPOUNDS ZENECA LIMITED (GB) 1995-04-27 — — WO disclosed
EP-0516297-A1 Pyridazinediones and their use in the treatment of neurological disorders ZENECA LIMITED (GB) 1992-12-02 — — EP disclosed
US-4923504-A 2-(2-Imidazolin-2-yl)pyridines and quinolines, and use of said compounds as herbicidal agents AMERICAN CYANAMID COMPANY (US) 1990-05-08 — — US disclosed
US-4798619-A 2-(2-imidazolin-2-yl)-pyridines and quinolines and use of said compounds as herbicidal agents AMERICAN CYANAMID CO. (US) 1989-01-17 — — US disclosed
US-4638068-A 2-(2-imidazolin-2-yl)-pyridines and quinolines, process and intermediates for the preparation thereof, and use of said compounds as herbicidal agents AMERICAN CYANAMID COMPANY (US) 1987-01-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110224343-A1 MODIFIER FOR AROMATIC POLYESTER AND AROMATIC POLYESTER RESIN COMPOSITION COMPRISING THE SAME F12, PHAX, WDR82 KDM4E 717/4885ALDH1A1 1882/4885HPGD 3275/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.